The epigenome comprises modifications in the chromatin, including DNA methylation and histone modifications, regulated by post-translational modifications (PTMs), which include the acetylation of H3 and H4, currently under development in anticancer agents, which potentiated the inhibition of the tumor and accompanied by TRAIL activation [53]. Here, TNFSF10 is linked to neoplasm.